Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome Approach
文献类型：期刊论文
| 作者 | Xue, H; Li, BJ; Zhang, J; Wu, ML; Huang, Q; Wu, Q; Sheng, HQ; Wu, DD; Hu, JW; Lai, MD |
| 刊名 | JOURNAL OF PROTEOME RESEARCH
 |
| 出版日期 | 2010 |
| 卷号 | 9期号:1页码:545-555 |
| 关键词 | biomarker colorectal cancer label-free quantitation metastasis secretome |
| 通讯作者 | Lai, MD (reprint author), Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, 188 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.,lmp@zju.edu.cn |
| 英文摘要 | Lymph node metastasis is the major concern that causes death in colorectal cancers. However, biomarkers for cancer metastasis are still lacking. In this study, we applied an LC-MS/MS-based label-free quantitative proteomics approach to compare the differential secretome of a primary cell line SW480 and its lymph node metastatic cell line SW620 from the same colorectal cancer patient. We identified a total of 910 proteins from the conditioned media and 145 differential proteins between SW480 and SW620 (>1.5-fold change). The differential expression pattern of 6 candidate proteins was validated by Western blot analysis. Among them, trefoil factor 3 and growth/differentiation factor 15, two up-regulated proteins in SW620, were further analyzed in a large cohort of clinical tissue and serum samples. Sandwich ELISA assay showed that the serum levels of both proteins were significantly higher in lymph node metastatic colorectal cancers. Receiver operating characteristic curve analysis confirmed that serum trefoil factor 3 and growth/differentiation factor 15 could provide a discriminatory diagnostic test for predicting colorectal cancer metastasis. Immunohistochemical analysis also showed that the overexpression of trefoil factor 3 or growth/differentiation factor 15 in colorectal cancer was associated with lymph node metastatic behavior. This study showed an accurate, sensitive, and robust label-free quantitation approach for differential analysis of cancer secretome. The comparison of the cancer secretome in vitro is a feasible strategy to obtain valuable biomarkers for potential clinical application. Both trefoil factor 3 and growth/differentiation factor 15 could serve as potential biomarkers for the prediction of colorectal cancer metastasis. |
| 学科主题 | Biochemistry & Molecular Biology |
| 类目[WOS] | Biochemical Research Methods |
| 关键词[WOS] | MACROPHAGE INHIBITORY CYTOKINE-1 ; INTESTINAL TREFOIL FACTOR ; TGF-BETA SUPERFAMILY ; FREE QUANTITATIVE PROTEOMICS ; TUMOR-DERIVED EXOSOMES ; HUMAN BREAST-CANCER ; PROSTATE-CANCER ; COLON-CANCER ; CELL-LINES ; MASS-SPECTROMETRY |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000273267900051 |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.143/handle/331003/933]  |
| 专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
| 推荐引用方式 GB/T 7714 | Xue, H,Li, BJ,Zhang, J,et al. Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome Approach[J]. JOURNAL OF PROTEOME RESEARCH,2010,9(1):545-555. |
| APA | Xue, H.,Li, BJ.,Zhang, J.,Wu, ML.,Huang, Q.,...&Lai, MD.(2010).Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome Approach.JOURNAL OF PROTEOME RESEARCH,9(1),545-555. |
| MLA | Xue, H,et al."Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome Approach".JOURNAL OF PROTEOME RESEARCH 9.1(2010):545-555. |
入库方式： OAI收割
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。